BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34635290)

  • 1. CARRA: The Childhood Arthritis and Rheumatology Research Alliance.
    Fuhlbrigge RC; Schanberg LE; Kimura Y
    Rheum Dis Clin North Am; 2021 Nov; 47(4):531-543. PubMed ID: 34635290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.
    Ringold S; Nigrovic PA; Feldman BM; Tomlinson GA; von Scheven E; Wallace CA; Huber AM; Schanberg LE; Li SC; Weiss PF; Fuhlbrigge RC; Morgan EM; Kimura Y
    Arthritis Rheumatol; 2018 May; 70(5):669-678. PubMed ID: 29333701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
    Beukelman T; Kimura Y; Ilowite NT; Mieszkalski K; Natter MD; Burrell G; Best B; Jones J; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):30. PubMed ID: 28416023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Smitherman EA; Chahine RA; Bitencourt N; Rahman AKMF; Lawson EF; Chang JC;
    J Rheumatol; 2023 Jan; 50(1):98-106. PubMed ID: 36109074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis.
    Ringold S; Weiss PF; Colbert RA; DeWitt EM; Lee T; Onel K; Prahalad S; Schneider R; Shenoi S; Vehe RK; Kimura Y;
    Arthritis Care Res (Hoboken); 2014 Jul; 66(7):1063-72. PubMed ID: 24339215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.
    Neely J; Ardalan K; Huber A; Kim S;
    Pediatr Rheumatol Online J; 2022 Jul; 20(1):50. PubMed ID: 35854378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
    Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
    Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
    Shenoi S; Nanda K; Schulert GS; Bohnsack JF; Cooper AM; Edghill B; Gillispie-Taylor MC; Goldberg B; Halyabar O; Mason TG; Ronis T; Schneider R; Vehe RK; Onel K;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):48. PubMed ID: 31331351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitioning youth with rheumatic conditions: perspectives of pediatric rheumatology providers in the United States and Canada.
    Chira P; Ronis T; Ardoin S; White P
    J Rheumatol; 2014 Apr; 41(4):768-79. PubMed ID: 24584912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    Zisman D; Gladman DD; Stoll ML; Strand V; Lavi I; Hsu JJ; Mellins ED;
    J Rheumatol; 2017 Mar; 44(3):342-351. PubMed ID: 28148698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus.
    Ota S; Cron RQ; Schanberg LE; O'Neil K; Mellins ED; Fuhlbrigge RC; Feldman BM
    Pediatr Rheumatol Online J; 2008 Apr; 6():5. PubMed ID: 18380905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB; Onel KB; Beukelman T; Ringold S
    J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in transitioning adolescents and young adults with rheumatologic diseases to adult Care in a Developing Country - the Brazilian experience.
    Anelli CG; Amorim ALM; Osaku FM; Terreri MT; Len CA; Reiff A
    Pediatr Rheumatol Online J; 2017 May; 15(1):47. PubMed ID: 28558790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry.
    Correll CK; Stryker S; Collier D; Phillips TA; Dennos AC; Balevic SJ; Beukelman T;
    RMD Open; 2023 May; 9(2):. PubMed ID: 37230760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Clinicians From 2010 to 2018.
    Johnson KR; Edens C; Sadun RE; Chira P; Hersh AO; Goh YI; Hui-Yuen J; Singer NG; Spiegel LR; Stinson JN; White PH; Lawson E;
    J Rheumatol; 2021 Sep; 48(9):1442-1449. PubMed ID: 33526621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset.
    Calvo I; Antón J; Bustabad S; Camacho M; de Inocencio J; Gamir ML; Graña J; La Cruz L; Robledillo JC; Medrano M; Merino R; Modesto C; Nuñez E; Rua MJ; Torrente-Segarra V; Vargas C; Carmona L; Loza E
    Rheumatol Int; 2015 Oct; 35(10):1615-24. PubMed ID: 25917856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases.
    Connelly M; Weiss JE;
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):72. PubMed ID: 31694655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transition in pediatric rheumatology-experiences from the pediatric rheumatism center Sankt Augustin].
    Klein A; Olbert F; Wintrich S; Lutz-Wiegers V; Horneff G
    Z Rheumatol; 2018 Oct; 77(8):677-684. PubMed ID: 30043177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.